Tiziana Schioppa

Title: Tiziana Schioppa: Innovator in Cancer Research

Introduction

Tiziana Schioppa is a prominent inventor based in London, GB. She has made significant contributions to the field of cancer research, particularly in the identification and treatment of cancer markers. With a total of 2 patents to her name, her work is paving the way for advancements in cancer diagnostics and therapeutics.

Latest Patents

One of Tiziana's latest patents focuses on the chemokine receptor CCR4 and its ligands CCL17 and CCL22. These components are utilized as markers for the identification and staging of cancer. Research indicates that the levels of CCR4, CCL17, and CCL22 increase during malignant tumor progression. This patent also outlines methods for stratifying cancer patients based on their suitability for treatment with anti-cancer agents. By measuring the levels of these markers in patient samples, diagnostic information can be obtained. Furthermore, her work includes methods of treatment for cancer patients using agents that modulate the activity of CCR4, CCL17, and CCL22, as well as screening for agents that can provide anti-cancer effects.

Career Highlights

Tiziana Schioppa is associated with Cancer Research Technology Limited, where she continues to advance her research in cancer therapeutics. Her innovative approaches have garnered attention in the scientific community, contributing to the ongoing fight against cancer.

Collaborations

Tiziana has collaborated with notable colleagues, including Yaohe Wang and Violet Slettenaar. These partnerships enhance the research efforts and broaden the impact of their findings in the field of cancer research.

Conclusion

Tiziana Schioppa's work in cancer research exemplifies the importance of innovation in medical science. Her patents and collaborations are crucial in developing effective cancer diagnostics and treatments.